Table 1b.
Estimated population attributable fraction (PAF, %) and cancer cases (N) and their 90% uncertainty intervals associated with excess body mass index by world region and cancer site in 2012, females.
| Region | Oesophageal adenocarcinoma |
Colon | Rectum | Gallbladder | Pancreas | Breast (postmenopausal) |
Corpus uteri | Ovary | Kidney | Total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PAF | N | PAF | N | PAF | N | PAF | N | PAF | N | PAF | N | PAF | N | PAF | N | PAF | N | N | PAF obesitya | PAF allb | |
| Sub-Saharan Africa | 27% (22%-33%) | 151 (122-182) | 5% (4%-6%) | 302 (235-381) | 2% (2%-3%) | 128 (96-167) | 20% (14%-27%) | 279 (195-373) | 6% (5%-7%) | 216 (176-262) | 6% (5%-8%) | 2759 (2079-3526) | 25% (19%-30%) | 2142 (1678-2619) | 2% (2%-3%) | 252 (178-339) | 11% (8%-15%) | 184 (127-252) | 6413 (4886-8102) | 8% (6%-10%) | 2-0% (1-5%-2-5%) |
| Middle East and Northern Africa | 44% (39%-48%) | 172 (153-189) | 11% (10%-12%) | 1254 (1145-1359) | 6% (5%-6%) | 334 (304-366) | 53% (48%-58%) | 1501 (1364-1631) | 12% (11%-13%) | 514 (470-556) | 15% (13%-17%) | 6760 (5912-7598) | 48% (45%-51%) | 4609 (4346-4881) | 6% (6%-7%) | 617 (547-691) | 35% (33%-37%) | 1256 (1181-1332) | 17018 (15421-18602) | 18% (16%-20%) | 7-0% (6-4%-7-7%) |
| Latin America & Caribbean | 41% (38%-44%) | 507 (473-537) | 9% (8%-10%) | 2670 (2415-2913) | 5% (4%-5%) | 603 (546-662) | 48% (44%-53%) | 4930 (4504-5361) | 10% (9%-10%) | 1377 (1255-1497) | 12% (11%-13%) | 12401 (11024-13797) | 42% (39%-44%) | 8022 (7424-8554) | 5% (5%-6%) | 900 (811-991) | 30% (28%-32%) | 2269 (2102-2425) | 33678 (30553-36736) | 16% (14%-17%) | 6-4% (5-8%-6-9%) |
| North America | 48% (47%-49%) | 706 (686-723) | 11% (11%-11%) | 6052 (5801-6276) | 6% (5%-6%) | 1009 (963-1053) | 53% (50%-57%) | 3131 (2959-3311) | 11% (11%-12%) | 2625 (2527-2715) | 14% (13%-15%) | 29741 (27095-32111) | 48% (47%-49%) | 26082 (25397-26677) | 7% (6%-7%) | 1554 (1469-1633) | 34% (33%-35%) | 8084 (7848-8296) | 78984 (74746-82796) | 19% (18%-20%) | 9-4% (8-9%-9-8%) |
| East Asia | 22% (19%-23%) | 582 (524-632) | 4% (4%-4%) | 4229 (3807-4668) | 2% (2%-2%) | 1228 (1103-1360) | 25% (22%-28%) | 10285 (9018-11500) | 4% (4%-4%) | 1796 (1617-1981) | 5% (4%-6%) | 8143 (7105-9252) | 20% (17%-21%) | 16920 (15093-18511) | 2% (2%-2%) | 965 (852-1087) | 14% (12%-15%) | 4045 (3657-4445) | 48192 (42775-53435) | 8% (7%-9%) | 3-0% (2-6%-3-3%) |
| South-East Asia | 22% (18%-26%) | 54 (45-64) | 4% (3%-4%) | 694 (581-820) | 2% (1%-2%) | 174 (146-208) | 23% (17%-29%) | 819 (616-1034) | 3% (3%-4%) | 200 (166-238) | 5% (4%-6%) | 2959 (2447-3511) | 19% (16%-22%) | 2842 (2415-3265) | 2% (2%-3%) | 399 (333-473) | 13% (11%-15%) | 321 (271-375) | 8465 (7019-9987) | 6% (5%-7%) | 2-2% (1-9%-2-6%) |
| South-Central Asia | 18% (14%-21%) | 289 (237-346) | 3% (3%-4%) | 636 (529-754) | 1% (1%-2%) | 227 (182-278) | 13% (10%-17%) | 2249 (1708-2916) | 3% (3%-4%) | 237 (191-288) | 4% (3%-5%) | 4736 (3755-5796) | 17% (13%-20%) | 3241 (2593-3908) | 2% (1%-2%) | 540 (426-667) | 12% (10%-14%) | 526 (440-617) | 12682 (10061-15569) | 5% (4%-7%) | 1-7% (1-3%-2-1%) |
| Eastern Europe | 46% (43%-50%) | 228 (209-243) | 11% (10%-12%) | 4543 (4121-4939) | 5% (5%-6%) | 1371 (1216-1527) | 53% (48%-57%) | 3450 (3133-3737) | 11% (10%-12%) | 1796 (1622-1961) | 13% (12%-15%) | 13337 (11582-15010) | 45% (41%-48%) | 18745 (17264-19981) | 6% (5%-7%) | 1639 (1450-1827) | 33% (30%-35%) | 5317 (4906-5705) | 50425 (45503-54931) | 18% (16%-20%) | 9-9% (8-9%-10-7%) |
| Northern Europe | 44% (42%-45%) | 579 (558-598) | 9% (9%-10%) | 1829 (1716-1936) | 5% (4%-5%) | 441 (413-471) | 47% (44%-51%) | 656 (607-707) | 10% (9%-10%) | 695 (654-733) | 12% (11%-13%) | 7513 (6790-8246) | 42% (40%-43%) | 5707 (5440-5947) | 6% (5%-6%) | 544 (504-584) | 30% (28%-31%) | 1728 (1640-1808) | 19693 (18321-21031) | 15% (14%-16%) | 7-9% (7-4%-8-4%) |
| Southern Europe | 44% (42%-46%) | 111 (105-116) | 10% (9%-10%) | 2943 (2737-3138) | 5% (5%-5%) | 647 (596-698) | 49% (45%-53%) | 2193 (2027-2356) | 10% (9%-10%) | 1122 (1042-1197) | 12% (11%-13%) | 9096 (8103-10074) | 41% (39%-43%) | 8013 (7509-8452) | 5% (5%-6%) | 672 (610-733) | 30% (28%-31%) | 2231 (2089-2359) | 27028 (24818-29123) | 15% (14%-17%) | 8-1% (7-5%-8-7%) |
| Western Europe | 42% (39%-45%) | 416 (388-443) | 9% (9%-10%) | 3707 (3416-4019) | 5% (4%-5%) | 875 (802-956) | 49% (45%-53%) | 2631 (2438-2843) | 10% (9%-10%) | 1533 (1420-1654) | 11% (10%-13%) | 14582 (12956-16283) | 41% (38%-43%) | 9562 (8951-10162) | 5% (5%-6%) | 758 (687-835) | 29% (27%-31%) | 3791 (3603-4105) | 37854 (34662-41301) | 15% (13%-16%) | 7-8% (7-1%-8-5%) |
| Oceania | 44% (42%-45%) | 67 (64-70) | 10% (9%-10%) | 592 (561-622) | 5% (5%-5%) | 122 (115-129) | 49% (46%-53%) | 222 (208-237) | 10% (9%-10%) | 158 (150-165) | 12% (11%-14%) | 1740 (1575-1908) | 42% (41%-44%) | 1287 (1231-1339) | 6% (5%-6%) | 108 (101-116) | 31% (29%-32%) | 428 (411-445) | 4722 (4416-5031) | 15% (14%-16%) | 7-2% (6-7%-7-6%) |
| Low HDIc | 14% (8%-20%) | 150 (86-221) | 3% (2%-4%) | 253 (143-384) | 1% (1%-2%) | 104 (60-158) | 12% (6%-19%) | 882 (444-1394) | 3% (2%-5%) | 138 (84-202) | 4% (3%-6%) | 2980 (1955-4152) | 17% (11%-24%) | 2005 (1289-2755) | 2% (1%-2%) | 301 (174-455) | 9% (5%-14%) | 234 (136-350) | 7048 (4370-10070) | 5% (3%-8%) | 1-5% (0-9%-2-1%) |
| Medium HDI | 23% (20%-25%) | 850 (760-932) | 4% (4%-5%) | 4112 (3615-4644) | 2% (2%-2%) | 1279 (1119-1452) | 23% (20%-26%) | 10150 (8776-11546) | 4% (4%-5%) | 1774 (1561-1996) | 6% (5%-7%) | 15466 (13194-17864) | 21% (18%-23%) | 21979 (19414-24325) | 2% (2%-3%) | 1814 (1563-2084) | 14% (13%-16%) | 4052 (3622-4500) | 61478 (53624-69342) | 8% (7%-9%) | 2-7% (2-4%-3-1%) |
| High HDI | 41% (39%-44%) | 796 (741-844) | 10% (9%-11%) | 6539 (5945-7100) | 5% (4%-6%) | 1845 (1647-2043) | 49% (45%-53%) | 6285 (5732-6823) | 10% (9%-11%) | 2692 (2446-2927) | 13% (11%-14%) | 24317 (21339-27228) | 44% (40%-46%) | 25125 (23184-26784) | 6% (5%-6%) | 2424 (2160-2691) | 32% (29%-34%) | 6604 (6115-7061) | 76626 (69310-83501) | 17% (15%-18%) | 7-5% (6-8%-8-2%) |
| Very high HDI | 44% (42%-46%) | 2066 (1976-2148) | 9% (8%-9%) | 18547 (17361-19696) | 4% (4%-5%) | 3933 (3654-4221) | 42% (38%-45%) | 15029 (13823-16244) | 9% (8%-10%) | 7665 (7198-8123) | 12% (11 %-13%) | 71005 (63936-77866) | 42% (40%-44%) | 58061 (55455-60433) | 5% (5%-6%) | 4409 (4071-4749) | 30% (28%-31%) | 19288 (18401-20251) | 200003 (185876-213731) | 15% (14%-17%) | 7-8% (7-2%-8-3%) |
| World | 34% (31%-36%) | 3862 (3564-4144) | 8% (7%-8%) | 29451 (27065-31824) | 4% (3%-4%) | 7160 (6480-7874) | 32% (29%-36%) | 32346 (28776-36007) | 8% (7%-8%) | 12269 (11289-13248) | 10% (9%-11%) | 113767 (100424-127111) | 34% (32%-36%) | 107172 (99342-114297) | 4% (4%-4%) | 8948 (7967-9978) | 26% (24%-28%) | 30179 (28273-32162) | 345154 (313180-376644) | 13% (12%-14%) | 5-4% (4-9%-5-9%) |
a
PAF obesity: proportion of obesity-related cancers (i.e. oesophageal adenocarcinoma, pancreas, kidney, postmenopausal breast, ovary, corpus uteri, gallbladder, colon, rectum)attributable to excess BMI
b
PAF all cancers: proportion of all cancer (excluding non-melanoma skin cancers) attributable to excess BMI
c
HDI: Human development index